A federal jury in West Virginia on Thursday awarded $18.5 million against Boston Scientific Corp. in the second verdict in federal court over one of its pelvic mesh devices.
The verdict came a week after a federal jury in Florida issued a $26.7 million verdict against the company for providing insufficient warnings about the risks of its Pinnacle mesh device. On Wednesday, a California appeals court upheld a $5.5 million award in the first jury verdict against pelvic mesh device manufacturer C.R. Bard Inc.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
